2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	causal interaction	3	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	diagnostic usage	2	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	diagnostic usage	1	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	therapeutic application	2	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	therapeutic application	4	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	therapeutic application	2	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	ongoing research	3	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/29026604/	Transglucosidase improves the bowel movements in type 2 diabetes mellitus patients: A preliminary randomized double-blind, placebo-controlled study.	ongoing research	2	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/22098444/	Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial.	ongoing research	3	
2.4.1.219	Diabetes Mellitus	https://pubmed.ncbi.nlm.nih.gov/23657005/	Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study.	unassigned	-